Galloway Heath H

Track

Insider profile

Galloway Heath H's trades of Accendra Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
69.19
Quantity 37,246 -43.4%
Value US$4,387,679
Transaction date
Proposed sale
Price
497.21
Quantity 42,815
Value US$2,926,085
Transaction date
Planned sale
Price
117.99
Quantity 49,080 -1.9%
Value US$660,027
Transaction date
Proposed sale
Price
20.18
Quantity 2,031
Value US$40,986
Transaction date
Planned sale
Price
19.91
Quantity 97 -0.3%
Value US$1,931
Transaction date
Proposed sale
Price
19.91
Quantity 97
Value US$1,931
Transaction date
Proposed sale
Price
17.57
Quantity 5,500
Value US$96,635
Transaction date
Planned sale
Price
17.57
Quantity 5,500 -13.1%
Value US$96,635
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-20 2024-05-17
PlS Planned sale
37,246 -43.4%
69.19
US$4,387,679 		37,246 -43.4% 69.19 US$4,387,679
2024-05-17 2024-05-17
PrS Proposed sale
42,815
497.21
US$2,926,085 		42,815 497.21 US$2,926,085
2024-05-20 2024-05-16
PlS Planned sale
49,080 -1.9%
117.99
US$660,027 		49,080 -1.9% 117.99 US$660,027
2024-05-16 2024-05-16
PrS Proposed sale
2,031
20.18
US$40,986 		2,031 20.18 US$40,986
2024-02-08 2024-02-07
PlS Planned sale
97 -0.3%
19.91
US$1,931 		97 -0.3% 19.91 US$1,931
2024-02-07 2024-02-07
PrS Proposed sale
97
19.91
US$1,931 		97 19.91 US$1,931
2023-11-13 2023-11-10
PrS Proposed sale
5,500
17.57
US$96,635 		5,500 17.57 US$96,635
2023-11-13 2023-11-10
PlS Planned sale
5,500 -13.1%
17.57
US$96,635 		5,500 -13.1% 17.57 US$96,635